Diffuse Thinning: What It Is, Why It Happens, and the Best Treatments

What Is Diffuse Thinning?

Diffuse thinning refers to hair loss all over the scalp. Treatment for diffuse thinning will vary depending on the cause, so understanding why it’s happening is an essential first step. If it’s caused by androgenic alopecia, then finasteride, oral or topical with or without minoxidil may be an effective treatment whereas if it’s telogen effluvium, then a doctor will recommend something else such as lifestyle or dietary adjustments sometimes in combination with medications. (Olsen et al., 2002) (Malkud, 2015)

Diffuse Thinning vs. Typical Male Pattern Baldness: The Fastest Ways to Tell

Male pattern baldness, often referred to as Androgenic Alopecia (or AGA) normally starts either at the hairline or the crown area at the top of the back of the head. Sometimes, hair loss will involve both areas at the same time. It follows a Norwood scale and generally, the hair falls out in a recognizable pattern over time. Diffuse thinning has no typical pattern and can happen all over the scalp at the same time. (Norwood, 1975)

If hair shedding started abruptly and began a few months after a trigger (such as illness, major emotional stress, surgery, medication changes, crash dieting), telogen effluvium is often the more likely explanation than classic male pattern baldness. (Malkud, 2015).

A doctor or trichologist can identify whether the hair loss is caused by AGA (androgenic alopecia) or telogen effluvium using a trichoscope/dermoscope to perform trichoscopy. This is a magnifying device that provides a close look at the scalp allow the specialist to see if the hair is miniaturizing or not before falling out. (Park et al., 2024) (Whiting, 1993)

Common Signs of Diffuse Thinning (Including “See-Through” Hair and Visible Scalp)

Diffuse thinning is recognizable when the hair density is low enough that the hair looks see-through and a large area of the scalp becomes visible instead of one visible bald spot or a receding hairline. (Rebora, 2019)

Another key differentiating factor that points towards diffuse thinning is when the hair falls out quickly (more than 100 hairs a day) and can easily be pulled out from anywhere on the scalp or is coming out in large volume during regular washing. (Li et al., 2022). Rapid hair loss is generally not AGA and more likely telogen effluvium.

Thinning Hair but Not Receding: What It Typically Means

When hair thins quickly, but without a receding hairline, then it’s normally diffuse shedding and caused by telogen effluvium. Male pattern baldness is called pattern baldness for good reason: it follows an easily observable pattern. (Malkud, 2015)

The AGA pattern is gradual and a trichoscopy will reveal hair miniturization with different hair shaft sizes that get smaller over time. (Kuczara et al., 2024).

The treatment for telogen effluvium or AGA is different and expectations for slowing or recovering hair loss might be different. . (Sinclair, 2004)

Balding at the Crown vs. Diffuse Thinning: What Each Pattern Suggests

If the hair is falling out on the crown of the head and causing a bald spot, the most likely cause is androgenic alopecia, and this often happens in combination with a receding hairline. (Hamilton, 1951) Diffuse thinning that is not localized to a specific area such as the hairline or crown, happens more quickly and often occurs after something changes in the person's life to trigger. (Harrison et al., 2009)

Causes of Diffuse Thinning or Hair Loss in Men

Diffuse thinning can be caused by a variety of possible triggers so make sure you inform your doctor if you have experienced any of the following:

• Acute illness with fever / infection (including post-viral states)
• Major surgery, anesthesia, or significant physical trauma/injury
• Major psychological stress or traumatic life events
• Rapid weight loss / crash dieting / low protein intake
• Starting, stopping, or changing systemic medications (telogen-effluvium–type shedding commonly begins weeks to months after a change)
• Thyroid dysfunction (especially hypothyroidism)
• Iron deficiency and other nutritional deficits (more likely when diet/restriction or absorption issues are present)
• Heavy metal exposure/toxicity (less common, but a recognized trigger category)
• Immune triggers for diffuse alopecia areata variants (infection, trauma, stress can precipitate flares in susceptible people)

The most common trigger of diffuse shedding is acute febrile illness or infection. This and stress are normally seen in patients experiencing telogen effluvium. (. Hughes, 2024)

Diffuse Thinning from Androgenetic Alopecia: When Male Pattern Baldness Looks Diffuse

There are cases where diffuse thinning is caused by androgenic alopecia which can be diagnosed using a trichoscopy to look for hair diameter variability (anisotrichosis) with more vellus hairs and other miniaturization signals. Even if the thinning is all over the scalp, it is still important to rule out AGA because the solution could still be finasteride and/or minoxidil. (Kuczara et al., 2024) (Kaufman et al., 1998)

Diffuse Unpatterned Hair Loss (DUPA): What It Is and Why It Matters

Diffuse unpatterned hair loss (DUPA) is hair miniaturization that extends beyond the areas normally associated with male pattern baldness and on the back and sides of the head. This is important to consider because hair transplants take hair from the back and insert it into areas where the hair has fallen out. Diffuse unpatterned vs diffuse patterned (DPA) require different solutions. Simply put, DPA can be fixed with hair transplantation and DUPA cannot. (True, 2021)

Diffuse Patterned Alopecia: How It Presents and How It’s Treated

Diffuse patterned alopecia (DPA) is patterned hair loss all over the scalp instead of the normal crown/bald spot and hairline recession associated with AGA. (True, 2021) The treatment is to address the DHT sensitivity with finasteride and if the hair has completely fallen out then DPA patients are also suitable for getting a hair transplant once the cause is stabilized. (Olsen et al., 2002)

Alopecia Areata That Looks Diffuse: When Autoimmune Hair Loss Mimics Shedding

Alopecia areata (AA) can be sudden, diffuse shedding without the obvious circular patches, which is why alopecia areata incognita (AAI) and diffuse alopecia areata are commonly mistaken for telogen effluvium. (Alessandrini et al., 2019). AAI is a AA sub-category that occurs quickly. A doctor should be able to determine the cause using trichoscopy and getting a biopsy and observing the timeline of the hair loss. (Rebora, 1987)

Labs and Tests to Confirm the Cause (What to Ask Your Doctor For)

If you’re unsure about what’s causing your hair loss, a doctor can perform a complete blood count) CBC, iron studies (especially ferritin which assesses your total body iron stores), and thyroid testing (TSH ± T3/T4). Some labs can also test for nutritional deficiencies like a lack of vitamin D and zinc. (Malkud, 2015) (Kakpovbia et al., 2021) If these don’t provide a clear reason for your diffuse shedding a scalp biopsy can help distinguish diffuse shedding ,more common with telogen effluvium from patterned miniaturization which is the pattern more commonly observed with AGA. (Whiting, 1993)

Is Diffuse Thinning Reversible?

Diffuse thinning caused by telogen effluvium is generally reversible, although not always complete, once the cause is identified and treated. If on the other hand, diffuse thinning is actually caused by AGA, then it’s less likely to be fully reversible, but is generally treatable with medications such as finasteride and/or minoxidil. (Malkud, 2015) (Kaufman et al., 1998) (Olsen et al., 2002)

Prescription Medication Options for Diffuse Thinning

Diffuse thinning caused by androgenic alopecia (AGA) can be treated with finasteride, dutasteride, minoxidil, or a combination of finasteride and minoxidil or dutasteride and minoxidil. The combination is generally most effective because finasteride or dutasteride address the hormonal cause of AGA, DHT sensitivity, while the minoxidil improves the quality of the hair that regrows, generally over a period of 6 months to one year. (Rossi et al., 2024). (Li et al., 2025)

Shampoo and Scalp Treatments That Support Hair Loss

If diffuse shedding is associated with scalp problems like inflammation and dandruff (such as with seborrheic dermatitis), then ketoconazole-based shampoo (typically 1–2%) can be used while the cause is brought under control. Anti-dandruff shampoos with ingredients such as ketoconazole, piroctone olamine, and zinc pyrithione can reduce the shedding from telogen effluvium by helping balance oils on the scalp. (Piérard-Franchimont et al., 1998) Sometimes a low dose topical steroid might be required to reduce inflammation in the scalp. Using steroid to scalp health is something you would want to discuss with your doctor before, as steroids have the potential to thin the skin and have systemic side effects, and therefore should not be used at high concentrations or for prolonged periods.

Why Your Hair Looks Worse Before It Looks Better (Shedding, Cycling, and Consistency)

Recovering from diffuse shedding takes time and for the first few months (and maybe up to6 months) you’ll likely see more hair fall out while the follicles “reset” and begin to grow healthy strands of hair again. (Headington, 1993). (Malkud, 2015) Minoxidil can speed up this process by shortening the telogen phase and pushing hair follicles back toward the growth or anagen phase, ridding older hairs first before the new hair grows back. (Panchaprateep and Lueangarun, 2020) Stay consistent with your treatment if you want to see optimal results even if the initial shedding seems excessive. By 6 months, shedding should have stopped and you should be starting to notice improvements again.

Final Thoughts: Diffuse Thinning Hair Loss in Men

Diffuse thinning is normally temporary and can be stopped once the cause is addressed and sometimes simply with time. If the cause is found to be androgenic alopecia, then managing the DHT sensitivity with medication, is usually sufficient to treat the condition and halt hair loss or induce new hair growth. Whether your hair loss was triggered by an event or caused by your genetics, trusting your doctor and following their advice is the best way to gain your precious hair again.

Dr. Simon Pimstone, MD PhD FRCPC

Physician-Scientist; Founder, Director, and Chief Executive Officer
XYON: Founder, Director, and CEO

Education
Doctorate of Medicine (MD) — University of Cape Town, South Africa — 1991
Genetics (PhD) — University of Amsterdam, The Netherlands — 1998
Internal Medicine (Postgraduate Fellowship) — University of British Columbia (UBC), Canada — 2001

Academic & Clinical Appointments
Clinical Assistant Professor, Division of General Internal Medicine — University of British Columbia
Associate Member, Division of Cardiology, Department of Medicine — University of British Columbia
Faculty — Providence Health Care Heart and Lung Institute

Learn More

References

Boujon, C. E., Bestetti, G. E., Meier, H. P., Straub, R., Junker, U., & Rossi, G. L. (1993). Equine pituitary adenoma: A functional and morphological study. Journal of Comparative Pathology, 109(2), 163–178. https://doi.org/10.1016/S0021-9975(08)80260-5

Schriger, D. L. (2020). Learning from the decrease in US emergency department visits in response to the Coronavirus Disease 2019 pandemic. JAMA Internal Medicine, 180(10), 1334–1335. https://doi.org/10.1001/jamainternmed.2020.3265

Piérard, G. E., Ries, G., & Cauwenbergh, G. (1998). New insight into the topical management of excessive sebum flow at the skin surface. Dermatology, 196(1), 126–129. https://doi.org/10.1159/000017845

Burtt, D. G., Stern, J. C., Webster, C. R., Hofmann, A. E., Franz, H. B., Sutter, B., Thorpe, M. T., Kite, E. S., Eigenbrode, J. L., Pavlov, A. A., House, C. H., Tutolo, B. M., Des Marais, D. J., Rampe, E. B., McAdam, A. C., & Malespin, C. A. (2024). Highly enriched carbon and oxygen isotopes in carbonate-derived CO2 at Gale crater, Mars. Proceedings of the National Academy of Sciences of the United States of America, 121(42), e2321342121. https://doi.org/10.1073/pnas.2321342121

Tang, L., Zhang, X.-Y., Liu, Y.-J., & Tong, S. (2023). Neural-network-based adaptive constrained control for switched systems under state-dependent switching law. IEEE Transactions on Neural Networks and Learning Systems, 34(8), 4057–4067. https://doi.org/10.1109/TNNLS.2021.3120999

Fenderson, L. E., Kovach, A. I., & Llamas, B. (2020). Spatiotemporal landscape genetics: Investigating ecology and evolution through space and time. Molecular Ecology, 29(2), 218–246. https://doi.org/10.1111/mec.15315

Aref, H. M., Shokri, H., Roushdy, T. M., Fathalla, F., & El Nahas, N. M. (2021). Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt. PLOS ONE, 16(7), e0254228. https://doi.org/10.1371/journal.pone.0254228

Harrison, S., & Bergfeld, W. (2009). Diffuse hair loss: Its triggers and management. Cleveland Clinic Journal of Medicine, 76(6), 361–367. https://doi.org/10.3949/ccjm.76a.08080

Hamilton, J. B. (1951). Patterned loss of hair in man: Types and incidence. Annals of the New York Academy of Sciences, 53(3), 708–728. https://doi.org/10.1111/j.1749-6632.1951.tb31971.x

Sinclair, R. (2004). Chronic telogen effluvium or early androgenetic alopecia? International Journal of Dermatology, 43(11), 842–843. https://doi.org/10.1111/j.1365-4632.2004.02034.x

Rebora, A. (2019). Telogen effluvium: A comprehensive review. Clinical, Cosmetic and Investigational Dermatology, 12, 583–590. https://doi.org/10.2147/CCID.S200471

Whiting, D. A. (1993). Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. Journal of the American Academy of Dermatology, 28(5 Pt 1), 755–763. https://doi.org/10.1016/0190-9622(93)70106-4

Park, H. U., Chung, K. B., & Kim, D.-Y. (2024). Quantitative measurement of hair diameter diversity as a diagnostic indicator of androgenetic alopecia in Korean males: A cross-sectional study. JAAD International, 15, 121–126. https://doi.org/10.1016/j.jdin.2024.02.005

Norwood, O. T. (1975). Male pattern baldness: Classification and incidence. Southern Medical Journal, 68(11), 1359–1365. https://doi.org/10.1097/00007611-197511000-00009

Malkud, S. (2015). Telogen effluvium: A review. Journal of Clinical and Diagnostic Research, 9(9), WE01–WE03. https://doi.org/10.7860/JCDR/2015/15219.6492

Olsen, E. A., Dunlap, F. E., Funicella, T., Koperski, J. A., Swinehart, J. M., Tschen, E. H., & Trancik, R. J. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology, 47(3), 377–385. https://doi.org/10.1067/mjd.2002.124088